On Invalid Date, Vera Therapeutics (NASDAQ: VERA) reported Q3 2023 earnings per share (EPS) of -$0.45, up 50.55% year over year. Total Vera Therapeutics earnings for the quarter were -$20.10 million. In the same quarter last year, Vera Therapeutics's earnings per share (EPS) was -$0.91.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.